ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 50 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2017. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $31,805 | -79.6% | 13,650 | -65.9% | 0.00% | – |
| Q4 2021 | $156,000 | +56.0% | 40,014 | +33.9% | 0.00% | -100.0% |
| Q1 2021 | $100,000 | -82.9% | 29,880 | -90.7% | 0.00% | -88.9% |
| Q2 2020 | $586,000 | +1262.8% | 322,225 | +662.8% | 0.01% | +800.0% |
| Q1 2020 | $43,000 | -68.6% | 42,243 | -35.8% | 0.00% | 0.0% |
| Q2 2019 | $137,000 | +104.5% | 65,848 | +395.1% | 0.00% | 0.0% |
| Q1 2018 | $67,000 | -2.9% | 13,300 | -2.2% | 0.00% | 0.0% |
| Q4 2017 | $69,000 | +7.8% | 13,600 | +32.0% | 0.00% | 0.0% |
| Q3 2017 | $64,000 | +93.9% | 10,300 | -23.1% | 0.00% | 0.0% |
| Q4 2016 | $33,000 | – | 13,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitefort Capital Management, LP | 11,895,477 | $24,147,818 | 12.66% |
| Two Seas Capital LP | 8,280,818 | $16,810,061 | 3.38% |
| FourWorld Capital Management LLC | 1,341,907 | $2,724,071 | 0.51% |
| Tejara Capital Ltd | 180,077 | $365,556 | 0.21% |
| Woodline Partners LP | 4,719,903 | $9,581,403 | 0.11% |
| Hudson Bay Capital Management LP | 8,299,808 | $16,848,610 | 0.07% |
| Kepos Capital LP | 155,691 | $316 | 0.06% |
| Virtus ETF Advisers LLC | 40,040 | $81,281 | 0.05% |
| Centiva Capital, LP | 1,071,705 | $2,175,561 | 0.05% |
| Kades & Cheifetz LLC | 20,000 | $40,600 | 0.03% |